AMSilk GmbH, a Munich-based industrial supplier of and pioneer in bio-engineered silk protein materials, announced that it has raised an additional €25 million in an extended Series C financing led by existing investor ATHOS (AT Newtec) and with participation from Novo Holdings, Cargill and MIG Capital. AMSilk’s technology platform, based ...